Translational Engineering in Cancer The Translational Engineering in Cancer (TEC) Program brings together 25 faculty, representing 12 departments at Dartmouth?s Geisel School of Medicine (Geisel), its Thayer School of Engineering and its Guarini School of Graduate and Advanced Studies; and the Dartmouth-Hitchcock Medical Center (DH), with research interests relevant to three central TEC Program themes: 1) Surgical image-guidance, 2) Radiation monitoring and guidance, and 3) Cellular/molecular detection and contrast. The shared goals of the TEC Program are to: 1) Utilize biophysical and bioengineering approaches to develop and translate new imaging, engineering and treatment technologies that improve the care of cancer patients; 2) Impact cancer detection, diagnosis, and treatment ? nationally, regionally, and within the NCCC catchment area especially for malignancies of the brain/CNS, breast, skin, head & neck, pancreas and prostate ? by providing access to novel imaging modalities, interventional protocols enhanced by imaging and image-guidance, and dosimetry technology for assessing radiation treatments; and 3) Translate laboratory results into clinical studies via development of novel technologies that fuel academic-industrial partnerships, as well as start-up ventures and other industry relationships, to drive Dartmouth-generated technology towards clinical dissemination with the goal of changing and improving practice. Peer-reviewed cancer-related research direct cost support currently totals $6.4M, with NCI funding representing 53% ($3.4M) and total direct costs summing to $6.5M. Thirteen (13) TEC Program Members currently have a total of 17 CCSG-defined R01-equivalent awards. Using the same definition of cancer-related direct costs in 2014 (i.e., excluding all indirects as well as training and administrative direct costs), peer-reviewed cancer-related research direct costs ($6.4M) are 44% less compared to 2014 ($11.3M), but 60% of the 2014 total ($7.0M) was attributable to one large BARDA award. Since 2015, the Program has 306 cancer-related publications, 51% (157) intra-programmatic, 25% (76) inter- programmatic, 51% (156) with investigators from other institutions, and 11% (28) in high impact journals (i.e., impact factor >8), which are uncommon in engineering publications. Compared to 2014, intra-programmatic remains high (51% and 60%), and inter-programmatic has increased, to 25% from 20%. During the proposed funding period, TEC will leverage new Center for Imaging Medicine facilities in the Williamson building and the significant expansion of Dartmouth?s Thayer School of Engineering Faculty and co-location with Computer Science, as part of a major capital campaign recently announced to grow significantly its imaging and image- guidance research base in surgical oncology.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
2P30CA023108-41
Application #
9855314
Study Section
Subcommittee I - Transistion to Independence (NCI)
Project Start
Project End
Budget Start
2019-12-01
Budget End
2020-11-30
Support Year
41
Fiscal Year
2020
Total Cost
Indirect Cost
Name
Dartmouth College
Department
Type
DUNS #
041027822
City
Hanover
State
NH
Country
United States
Zip Code
03755
Rodriguez-Garcia, Marta; Fortier, Jared M; Barr, Fiona D et al. (2018) Aging impacts CD103+ CD8+ T cell presence and induction by dendritic cells in the genital tract. Aging Cell 17:e12733
Shajani-Yi, Zahra; de Abreu, Francine B; Peterson, Jason D et al. (2018) Frequency of Somatic TP53 Mutations in Combination with Known Pathogenic Mutations in Colon Adenocarcinoma, Non-Small Cell Lung Carcinoma, and Gliomas as Identified by Next-Generation Sequencing. Neoplasia 20:256-262
Shee, Kevin; Jiang, Amanda; Varn, Frederick S et al. (2018) Cytokine sensitivity screening highlights BMP4 pathway signaling as a therapeutic opportunity in ER+ breast cancer. FASEB J :fj201801241R
Bossé, Yohan; Amos, Christopher I (2018) A Decade of GWAS Results in Lung Cancer. Cancer Epidemiol Biomarkers Prev 27:363-379
Pande, Mala; Joon, Aron; Brewster, Abenaa M et al. (2018) Genetic susceptibility markers for a breast-colorectal cancer phenotype: Exploratory results from genome-wide association studies. PLoS One 13:e0196245
Szczepiorkowski, Zbigniew M; Burnett, Christine A; Dumont, Larry J et al. (2018) Apheresis buffy coat collection without photoactivation has no effect on apoptosis, cell proliferation, and total viability of mononuclear cells collected using photopheresis systems. Transfusion 58:943-950
Gorlova, Olga Y; Li, Yafang; Gorlov, Ivan et al. (2018) Gene-level association analysis of systemic sclerosis: A comparison of African-Americans and White populations. PLoS One 13:e0189498
Schmit, Stephanie L; Edlund, Christopher K; Schumacher, Fredrick R et al. (2018) Novel Common Genetic Susceptibility Loci for Colorectal Cancer. J Natl Cancer Inst :
Smith, T Jarrod; Sondermann, Holger; O'Toole, George A (2018) Co-opting the Lap System of Pseudomonas fluorescens To Reversibly Customize Bacterial Cell Surfaces. ACS Synth Biol 7:2612-2617
Trentham-Dietz, Amy; Ergun, Mehmet Ali; Alagoz, Oguzhan et al. (2018) Comparative effectiveness of incorporating a hypothetical DCIS prognostic marker into breast cancer screening. Breast Cancer Res Treat 168:229-239

Showing the most recent 10 out of 1911 publications